Back to Directory
Sevenless Therapeutics
South East England
Founded 2020
Preclinical small-molecule therapeutics targeting a novel pathway in chronic pain
Sevenless Therapeutics is a preclinical biotechnology company developing small-molecule medicines for people with chronic pain that responds poorly to existing treatments.
The company has identified a new target in pain signalling using computational and mathematical modelling approaches and is designing small molecules against it.
Its founding team brings experience in central nervous system pharmacology, pain and inflammation research, and pharmaceutical research and development.